BRIEF published on 08/09/2024 at 17:09, 2 years ago Les filiales de Vita 34 concluent un accord avec un concédant de licence américain Vita 34 FamiCordTx PBKM Technologie CAR-T Accord Sur Les Biotechnologies
BRIEF published on 08/09/2024 at 17:09, 2 years ago Subsidiaries of Vita 34 Reach Agreement with US Licensor Vita 34 FamiCordTx PBKM CAR-T Technology Biotechnology Agreement
PRESS RELEASE published on 08/09/2024 at 17:04, 2 years ago EQS-Adhoc: Subsidiaries of Vita 34 reach agreement with US licensor Vita 34 AG subsidiaries reach agreement with US licensor on CAR-T technology, settling previous lawsuit and securing new know-how licensing agreement Vita 34 AG Agreement Subsidiaries CAR-T Technology US Licensor
BRIEF published on 08/01/2024 at 12:44, 2 years ago Thomas Pfaadt nommé nouveau directeur financier de Vita 34 AG Conseil D'administration Finance Vita 34 AG Directeur Financier Thomas Pfaadt
BRIEF published on 08/01/2024 at 12:44, 2 years ago Thomas Pfaadt Appointed as New Chief Financial Officer of Vita 34 AG Chief Financial Officer Finance Management Board Vita 34 AG Thomas Pfaadt
PRESS RELEASE published on 08/01/2024 at 12:39, 2 years ago Thomas Pfaadt appointed as new Chief Financial Officer of Vita 34 AG Thomas Pfaadt appointed as new CFO of Vita 34 AG, bringing 20+ years of experience. Management Board complete. Vita 34, leading cell bank in Europe, focusing on cell banking and investments in therapies CFO Vita 34 AG Investments Thomas Pfaadt Cell Banking
PRESS RELEASE published on 06/04/2024 at 18:36, 2 years 2 months ago Original-Research: Vita 34 AG (von Montega AG): Halten Vita 34 AG steigert Umsatz in Q1 um 3,6% auf 18,6 Mio. EUR. Montega AG empfiehlt Halten mit Kursziel 6,00 EUR. Analyse von Tim Kruse (CFA). Lizenzverfahren CAR-T bleibt offen Montega AG Vita 34 AG Umsatzsteigerung Halten Lizenzverfahren CAR-T
BRIEF published on 05/31/2024 at 08:38, 2 years 2 months ago Vita 34 Reports Significant Increases in Earnings and Cash Flow EBITDA Revenue Growth Operating Cash Flow Q1 2024 Earnings Vita 34
BRIEF published on 05/31/2024 at 08:38, 2 years 2 months ago Vita 34 annonce des augmentations significatives de ses bénéfices et de ses flux de trésorerie Hausse Des Revenus BAIIA Résultats Du Premier Trimestre 2024 Vie 34 Flux De Trésorerie Opérationnel
PRESS RELEASE published on 05/31/2024 at 08:33, 2 years 2 months ago Vita 34 significantly increases earnings and operating cash flow in the first quarter Vita 34 AG reports a significant increase in earnings and operating cash flow in the first quarter of 2024, with revenues up by 3.6% to EUR 18.6 million. EBITDA exceeds EUR 1.5 million Revenues Business Development Earnings Operating Cash Flow Vita 34 AG
Published on 08/15/2026 at 00:50, 7 hours 14 minutes ago Revive Therapeutics Reports Grant of Options
Published on 08/15/2026 at 00:15, 7 hours 49 minutes ago Full Circle Lithium Announces Closing of Private Placement
Published on 08/14/2026 at 23:45, 8 hours 19 minutes ago AI/ML Innovations Inc. Announces Proposed Private Placement
Published on 08/14/2026 at 23:25, 8 hours 39 minutes ago NuRAN Wireless Closes $7.6 Million Financing
Published on 08/14/2026 at 23:00, 9 hours 4 minutes ago Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call
Published on 08/14/2026 at 18:15, 13 hours 49 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/14/2026 at 16:05, 15 hours 59 minutes ago GATORADE WELCOMES AITANA BONMATÍ TO TEAM GATORADE AHEAD OF THE NEW FOOTBALL SEASON
Published on 08/14/2026 at 15:29, 16 hours 35 minutes ago Tradegate AG publishes its half-year report
Published on 08/13/2026 at 18:00, 1 day 14 hours ago Chiffre d’affaires du 1er trimestre 2026-27 : 14,4 M€
Published on 08/11/2026 at 17:45, 3 days 14 hours ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 3 days 14 hours ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 4 days 14 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 4 days 14 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
